SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-003349
Filing Date
2018-02-09
Accepted
2018-02-09 09:46:39
Documents
2
Period of Report
2018-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1585
2 EX-24 DOCUMENT attachment1.htm EX-24 3367
  Complete submission text file 0000899243-18-003349.txt   6263
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVE. LEXINGTON MA 02421
Business Address
Sprague John M (Reporting) CIK: 0001730056 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36571 | Film No.: 18588861